Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;8(5):e661-e671.
doi: 10.1016/S2214-109X(20)30109-1.

Frequency and management of maternal infection in health facilities in 52 countries (GLOSS): a 1-week inception cohort study

Collaborators

Frequency and management of maternal infection in health facilities in 52 countries (GLOSS): a 1-week inception cohort study

WHO Global Maternal Sepsis Study (GLOSS) Research Group. Lancet Glob Health. 2020 May.

Abstract

Background: Maternal infections are an important cause of maternal mortality and severe maternal morbidity. We report the main findings of the WHO Global Maternal Sepsis Study, which aimed to assess the frequency of maternal infections in health facilities, according to maternal characteristics and outcomes, and coverage of core practices for early identification and management.

Methods: We did a facility-based, prospective, 1-week inception cohort study in 713 health facilities providing obstetric, midwifery, or abortion care, or where women could be admitted because of complications of pregnancy, childbirth, post-partum, or post-abortion, in 52 low-income and middle-income countries (LMICs) and high-income countries (HICs). We obtained data from hospital records for all pregnant or recently pregnant women hospitalised with suspected or confirmed infection. We calculated ratios of infection and infection-related severe maternal outcomes (ie, death or near-miss) per 1000 livebirths and the proportion of intrahospital fatalities across country income groups, as well as the distribution of demographic, obstetric, clinical characteristics and outcomes, and coverage of a set of core practices for identification and management across infection severity groups.

Findings: Between Nov 28, 2017, and Dec 4, 2017, of 2965 women assessed for eligibility, 2850 pregnant or recently pregnant women with suspected or confirmed infection were included. 70·4 (95% CI 67·7-73·1) hospitalised women per 1000 livebirths had a maternal infection, and 10·9 (9·8-12·0) women per 1000 livebirths presented with infection-related (underlying or contributing cause) severe maternal outcomes. Highest ratios were observed in LMICs and the lowest in HICs. The proportion of intrahospital fatalities was 6·8% among women with severe maternal outcomes, with the highest proportion in low-income countries. Infection-related maternal deaths represented more than half of the intrahospital deaths. Around two-thirds (63·9%, n=1821) of the women had a complete set of vital signs recorded, or received antimicrobials the day of suspicion or diagnosis of the infection (70·2%, n=1875), without marked differences across severity groups.

Interpretation: The frequency of maternal infections requiring management in health facilities is high. Our results suggest that contribution of direct (obstetric) and indirect (non-obstetric) infections to overall maternal deaths is greater than previously thought. Improvement of early identification is urgently needed, as well as prompt management of women with infections in health facilities by implementing effective evidence-based practices.

Funding: UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, WHO, Merck for Mothers, and United States Agency for International Development.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Countries participating in the global maternal sepsis study Eligible health facilities in purposively selected geographical areas in each country participated in the study. The boundaries shown on this map do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, or concerning the delimitation of its frontiers or boundaries.
Figure 2
Figure 2
Study profile Percentages are shown as n of total sample. There were 713 health facilities in 52 countries. *2580 women included using full protocol, 290 women included using modified protocol in western European countries (Belgium, Denmark, Italy, Spain, the Netherlands, the UK). †Source of infection clinically, radiologically, or microbiologically confirmed. ‡Includes women who had an invasive procedure to treat the source of infection (vacuum aspiration, dilatation and curettage, wound debridement, drainage [incision, percutaneous, culdotomy], laparotomy and lavage, other surgery), admission to intensive care or high dependency unit, or transfer to another facility. §Maternal death or near-miss. ¶At least one WHO near-miss criteria. ||Includes seven deaths due to direct (obstetric) cause, five due to abortion, six due to indirect (non-obstetric) cause (respiratory infection, meningitis, gastrointestinal). **Includes two deaths due to obstetric haemorrhage, one hypertensive disorder, one other direct cause, two indirect cause, two with unknown cause.

Similar articles

Cited by

  • Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries.
    WHO ACTION Trials Collaborators; Oladapo OT, Vogel JP, Piaggio G, Nguyen MH, Althabe F, Gülmezoglu AM, Bahl R, Rao SPN, De Costa A, Gupta S, Baqui AH, Khanam R, Shahidullah M, Chowdhury SB, Ahmed S, Begum N, D Roy A, Shahed MA, Jaben IA, Yasmin F, Rahman MM, Ara A, Khatoon S, Ara G, Akter S, Akhter N, Dey PR, Sabur MA, Azad MT, Choudhury SF, Matin MA, Goudar SS, Dhaded SM, Metgud MC, Pujar YV, Somannavar MS, Vernekar SS, Herekar VR, Bidri SR, Mathapati SS, Patil PG, Patil MM, Gudadinni MR, Bijapure HR, Mallapur AA, Katageri GM, Chikkamath SB, Yelamali BC, Pol RR, Misra SS, Das L, Nanda S, Nayak RB, Singh B, Qureshi Z, Were F, Osoti A, Gwako G, Laving A, Kinuthia J, Mohamed H, Aliyan N, Barassa A, Kibaru E, Mbuga M, Thuranira L, Githua NJ, Lusweti B, Ayede AI, Falade AG, Adesina OA, Agunloye AM, Iyiola OO, Sanni W, Ejinkeonye IK, Idris HA, Okoli CV, Irinyenikan TA, Olubosede OA, Bello O, Omololu OM, Olutekunbi OA, Akintan AL, Owa OO, Oluwafemi RO, Eniowo IP, Fabamwo AO, Disu EA, Agbara JO, Adejuyigbe EA, Kuti O, Anyabolu HC, Awowole IO, Fehintola AO, Kuti BP, Isah AD, Olateju EK, Abiodun O, Dedeke OF, Akinkunmi FB, Oyeneyin L, Adesiyun O, Raji HO, Ande ABA, Okonkwo I, Ariff S, Soof… See abstract for full author list ➔ WHO ACTION Trials Collaborators, et al. N Engl J Med. 2020 Dec 24;383(26):2514-2525. doi: 10.1056/NEJMoa2022398. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33095526 Free PMC article. Clinical Trial.
  • Critical factors associated with postpartum maternal death in Ethiopia.
    Tesfay N, Tariku R, Zenebe A, Woldeyohannes F. Tesfay N, et al. PLoS One. 2022 Jun 24;17(6):e0270495. doi: 10.1371/journal.pone.0270495. eCollection 2022. PLoS One. 2022. PMID: 35749471 Free PMC article.
  • Prevention of Neurological Sequelae in Preterm Infants.
    Gonzalez-Moreira E, Harmony T, Hinojosa-Rodríguez M, Carrillo-Prado C, Juárez-Colín ME, Gutiérrez-Hernández CC, Carlier MEM, Cubero-Rego L, Castro-Chavira SA, Fernández T. Gonzalez-Moreira E, et al. Brain Sci. 2023 May 2;13(5):753. doi: 10.3390/brainsci13050753. Brain Sci. 2023. PMID: 37239225 Free PMC article.
  • Factors affecting the use of antibiotics and antiseptics to prevent maternal infection at birth: A global mixed-methods systematic review.
    Eddy KE, Zahroh RI, Bohren MA, Bonet M, Homer CSE, Vogel JP. Eddy KE, et al. PLoS One. 2022 Sep 1;17(9):e0272982. doi: 10.1371/journal.pone.0272982. eCollection 2022. PLoS One. 2022. PMID: 36048776 Free PMC article.
  • Interventions to Prevent and Manage Infections in Pregnancy.
    Yasin R, Jiang L, Das JK, Bhutta ZA. Yasin R, et al. Neonatology. 2025;122(Suppl 1):32-41. doi: 10.1159/000543690. Epub 2025 Jan 28. Neonatology. 2025. PMID: 39874953 Free PMC article.

References

    1. Say L, Chou D, Gemmill A. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323–e333. - PubMed
    1. Souza JP, Gülmezoglu AM, Vogel J. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet. 2013;381:1747–1755. - PubMed
    1. Global Maternal and Neonatal Sepsis Initiative Working Group The Global Maternal and Neonatal Sepsis Initiative: a call for collaboration and action by 2030. Lancet Glob Health. 2017;5:e390–e391. - PubMed
    1. Singer M, Deutschman CS, Seymour CW. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801–810. - PMC - PubMed
    1. WHO . World Health Organization; Geneva, Switzerland: 2012. The WHO application of ICD-10 to deaths during pregnancy, childbirth and puerperium: ICD MM.https://apps.who.int/iris/bitstream/handle/10665/70929/9789241548458_eng...

Publication types